AMGN vs. NVAX

In the year-to-date period, AMGN achieves a 12.44% return, which is significantly higher than NVAX's -8.71% return. Over the past 10 years, AMGN has outperformed NVAX with an annualized return of 9.45%, while NVAX has yielded a comparatively lower -27.29% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Amgen Inc. (AMGN) and Novavax, Inc. (NVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AMGN Sharpe Ratio is -0.05, which is higher than the NVAX Sharpe Ratio of -0.55. The chart below compares the historical Sharpe Ratios of AMGN and NVAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

AMGN's dividend yield for the trailing twelve months is around 3.21%, while NVAX has not paid dividends to shareholders.

The maximum AMGN drawdown since its inception was -78.04%, smaller than the maximum NVAX drawdown of -98.82%. Use the drawdown chart below to compare losses from any high point for AMGN and NVAX.

The current volatility for Amgen Inc. (AMGN) is 9.43%, while Novavax, Inc. (NVAX) has a volatility of 27.71%. This indicates that AMGN experiences smaller price fluctuations and is considered to be less risky than NVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Amgen Inc. and Novavax, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.